Loading...
OTC Markets
Totals
Securities
12,309
Dollar Vol
$485.8M
Share Vol
756M
Trades
46,117

OTC Markets Group uses cookies and similar technologies to help us understand how you use our websites, as further disclosed in our Privacy Policy. Our Terms of Service contain important information including restrictions on your use of our websites. By clicking “Accept”, or by continuing to use our websites, you consent to the use of cookies and agree to the terms of the OTC Markets Group Privacy Policy and Terms of Service.

ATRA
Atara Biotherapeutics, Inc.

Common Stock

9.16

-0.11

-1.19%

Delayed (15 Min) Trade Data: 10:04am 07/16/2025
Filings and Disclosure
OTC Disclosure & News Service
Active
Inactive
All

The company has not provided financial reports or other disclosures to OTC Markets Group.

SEC Filings
Form Type
Form Type
Received
Received
Period End Date
Period End Date
Report
Report
8-K07/14/202507/14/2025PDFRTFHTMLXLS
406/12/202506/10/2025PDFRTFHTMLXLS
406/12/202506/10/2025PDFRTFHTMLXLS
406/12/202506/10/2025PDFRTFHTMLXLS
406/12/202506/10/2025PDFRTFHTMLXLS
406/12/202506/10/2025PDFRTFHTMLXLS
406/12/202506/10/2025PDFRTFHTMLXLS
8-K06/11/202506/10/2025PDFRTFHTMLXLS
SC 13D05/23/2025PDFRTFHTML
305/23/202505/16/2025PDFRTFHTMLXLS
More
Displaying 10 of 1026 Filings
Insider Disclosure
OTC Disclosure & News

No insider disclosure available for ATRA.

SEC Transactions Last 6 Months
Buy / Sell
Buys
8
Sells
5
Total
13
Shares
Bought
156,590
Sold
11,095
Gross
167,685
Net
145,495
SEC Transactions Last 2 Years
Nasdaq
Daily Advancers
Subscribe to Our Newsletter
Stay up to date on the latest company news, industry trends and regulatory changes that affect our markets and learn about members of our community.